目的：了解2014 年版《军队合理医疗药品目录》（简称《药品目录》）的实施情况及存在问题。方法：汇总、分析实地调研资

料，对2013、2014 年南京、兰州、成都、沈阳4 个军区的总医院、军医大学附属医院、中心医院、机关门诊部、干休所卫生所（共20 个）

中军队患者与地方医保患者的用药数据进行对比分析。结果与结论：与2013 年相比，2014 年4 个军区各医疗机构所使用《药品目

录》中的药品品种数均有所增加，其中增幅最大的是中心医院，平均达12.2％；增幅最小的是总医院，平均仅为4.8％。在使用《药

品目录》的品种数中，中心医院累计覆盖率最高，平均为83.3％；其次是军医大学附属医院，平均为80.6％；干休所卫生所较低，仅

为63.9％。军队患者的住院、门诊治疗人均药品费用增幅分别为15.0％、18.0％，但仍与同期地方医保患者存在差异。建议根据调

研情况，定期对《药品目录》执行情况开展监测评价，为今后《药品目录》的修订提供参考。

OBJECTIVE：To know about the implementation and existing problems of current Reasonable Medicine List for Military（

Medicine List for short）（2014 edition）. METHODS：The data of field investigation were summarized and analyzed. Comparative

analysis was made to the data of medicines used by military patients and local insured patients in the general hospitals，hospitals

affiliated to the military medical university，central hospitals，authorities’clinics and cadre’s sanitariums’clinics（a total of

20）of 4 military regions in Nanjing，Lanzhou，Chengdu and Shenyang before and after the modification of the Medicine List. RESULTS

& CONCLUSIONS：After the modification of the Medicine List，all the above-mentioned medical institutions of the 4 military

regions used more varieties of medicines as set forth in the Medicine List，where there was the highest average increase up to

12.2％ in the varieties of the medicines used by central hospitals，and the lowest average increase of 4.8％ in those by general hospitals.

Central hospitals used the largest number of varieties of medicines as set forth in the Medicine List，accounting for 83.3％ of

all varieties in the Medicine List on average；followed by hospitals affiliated to the military medical university，accounting for

80.6％ on average；and the cadre’s sanitariums’clinics used a smaller number of varieties thereof，only accounting for 63.9％. For

military inpatients and outpatients，the medicine expense per capita increased by 15.0％ and 18.0％ respectively，which was different

from that for local insured patients in the same period. It is suggested that the implementation of the Medicine List should be

monitored and evaluated on a regular basis pursuant to the survey，to provide a reference for future adjustment of the Medicine

List.